Vistagen grants 75,000-share options to CEO, CFO, and three other executives at $0.5358

Vistagen Therapeutics, Inc.

Options granted to five executives: CEO Shawn Singh, CLO Reid Adler, CDO Elissa Cote, COO Joshua Prince, CFO Nick Tressler.
Each option covers 75,000 shares; exercise price $0.5358 per share.
Vesting: 25% at 6 months, then 25% every 6 months thereafter, fully vested in 2 years.
Granted under Amended and Restated 2019 Omnibus Equity Incentive Plan.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.